These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33667957)

  • 41. Targeting PD-L1 (Programmed death-ligand 1) and inhibiting the expression of IGF2BP2 (Insulin-like growth factor 2 mRNA-binding protein 2) affect the proliferation and apoptosis of hypopharyngeal carcinoma cells.
    Yang X; Liu J
    Bioengineered; 2021 Dec; 12(1):7755-7764. PubMed ID: 34608837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reproducibility of PD-L1 immunohistochemistry interpretation across various types of genitourinary and head/neck carcinomas, antibody clones, and tissue types.
    Wang C; Hahn E; Slodkowska E; Eskander A; Enepekides D; Higgins K; Vesprini D; Liu SK; Downes MR; Xu B
    Hum Pathol; 2018 Dec; 82():131-139. PubMed ID: 30075156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
    Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
    J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of cytotoxicity of a purified venom protein from Naja kaouthia (NKCT1) using gold nanoparticles for targeted delivery to cancer cell.
    Bhowmik T; Saha PP; Sarkar A; Gomes A
    Chem Biol Interact; 2017 Jan; 261():35-49. PubMed ID: 27836789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
    Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
    Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PD‑L1 promotes head and neck squamous cell carcinoma cell growth through mTOR signaling.
    Zheng A; Li F; Chen F; Zuo J; Wang L; Wang Y; Chen S; Xiao B; Tao Z
    Oncol Rep; 2019 May; 41(5):2833-2843. PubMed ID: 30864729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions.
    Yin W; Cheepala S; Roberts JN; Syson-Chan K; DiGiovanni J; Clifford JL
    Mol Cancer; 2006 Apr; 5():15. PubMed ID: 16603078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma.
    Zhou AL; Wang X; Yu W; Yang L; Wei F; Sun Q; Wang Y; Kou F; Dong R; Ren X; Zhang X
    Pathol Res Pract; 2020 Sep; 216(9):153093. PubMed ID: 32825960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RhoA/ROCKs signaling is increased by treatment with TKI-258 and leads to increased apoptosis in SCC-4 oral squamous cell carcinoma cell line.
    Carneiro ACDM; De Vito FB; Moraes-Souza H; Crema VO
    J Oral Pathol Med; 2021 Apr; 50(4):394-402. PubMed ID: 33222274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Programmed Death Ligand-1 Overexpression with the Grade and Stage of Oral Squamous Cell Carcinoma.
    Qureshi ZM; Qamar S
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):662-664. PubMed ID: 32703358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways.
    Ke JY; Zhang W; Gong RS; Cen WJ; Huang HQ; Li YR; Kong WD; Jiang JW
    Tumour Biol; 2016 Nov; 37(11):14863-14872. PubMed ID: 27644244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction.
    Overholser J; Guo L; Kaumaya PTP
    J Vis Exp; 2023 Jul; (197):. PubMed ID: 37486131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation.
    Morsch R; Rose M; Maurer A; Cassataro MA; Braunschweig T; Knüchel R; Vögeli TA; Ecke T; Eckstein M; Weyerer V; Esposito I; Ackermann M; Niegisch G; Gaisa NT;
    BMC Cancer; 2020 Mar; 20(1):230. PubMed ID: 32188412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of ethyl acetate extract of peony (Paeonia suffruticosa) seed coat on the proliferation and apoptosis of oral squamous carcinoma cells through miR-424-3p/STAT3/Survivin pathway.
    Ren S; Qing S
    Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):52-58. PubMed ID: 33040785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy.
    Zhang L; Zhao Y; Tu Q; Xue X; Zhu X; Zhao KN
    Curr Med Chem; 2021; 28(5):893-909. PubMed ID: 32003657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered expression of programmed death-ligand 1 after neo-adjuvant chemotherapy in patients with lung squamous cell carcinoma.
    Song Z; Yu X; Zhang Y
    Lung Cancer; 2016 Sep; 99():166-71. PubMed ID: 27565935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinoma.
    Evrard D; Hourseau M; Couvelard A; Paradis V; Gauthier H; Raymond E; Halimi C; Barry B; Faivre S
    Oncoimmunology; 2020 Nov; 9(1):1844403. PubMed ID: 33299655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-375 inhibits IFN-γ-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.
    Wu Q; Zhao Y; Sun Y; Yan X; Wang P
    Oncol Rep; 2018 Mar; 39(3):1461-1468. PubMed ID: 29328389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-inhibition of BET proteins and PD-L1 as a potential therapy for OSCC through synergistic inhibition of FOXM1 and PD-L1 expressions.
    Wang W; Tan J
    J Oral Pathol Med; 2019 Oct; 48(9):817-825. PubMed ID: 31177574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-Cancer Activity of the Combinational Treatment of Noozone Cold Plasma with p-FAK Antibody-Conjugated Gold Nanoparticles in OSCC Xenograft Mice.
    Choi JH; Gu HJ; Park KH; Hwang DS; Kim GC
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.